Affiliation:
1. Unit of Dermatology, Department of Medical, Surgical and Neurological Sciences University of Siena Siena Italy
2. Department of Medical Biotechnologies University of Siena Siena Italy
Abstract
AbstractObjectivesActinic keratosis have a high risk of progression to a squamous cell carcinoma. Insulin‐like growth factor 1 and its receptor play a relevant role in restoring repair of ultraviolet‐induced cell damage. This pathway is reduced in patients older than 65 years. Ablative fractional laser resurfacing could normalize insulin‐like growth factor 1 (IGF‐1) secretion in elderly by recruiting new fibroblasts. The aim of the study is to evaluate restoration of IGF1 values by PCR in senescent fibroblasts after ablative fractional laser resurfacing.MethodsWe enrolled 30 male patients with multiple actinic keratosis on the scalp, equally divided into two mirror areas of up to 50 cm2, treating only the right one. We performed one skin biopsy for each area 30 days after treatment. Real‐time PCR in fibroblasts was performed to assess the change in IGF1. At baseline and after 6 months, in vivo reflectance confocal microscopy examination was performed in all patients.ResultsIGF1 values were increased in the treated side by about 60%. The right areas had fairly complete resolution of actinic keratosis at the last follow‐up visit after 6 months with no appearance of new lesions. The mean number of actinic keratosis in the right area was reduced by more than 75% at four‐ and six‐follow‐up visits compared to the left area. The improvement in the right area was also evidenced by lower values of the mean AKASI (actinic keratosis area and severity index) score. Reflectance confocal microscopy showed a reduction of keratinocytic disarray and scales after treatment.DiscussionTaken together, all the clinical, laboratory, and in vivo results of our study allowed us to confirm that ablative fractional laser resurfacing is a valuable tool for the treatment of actinic keratosis and cancerization field, both for the management of clinically evident lesions and for preventing the occurrence of squamous cell carcinoma.